Materias dentro de su búsqueda.
Mostrando 24,121 - 24,140 Resultados de 24,879 Para Buscar '".eu"', tiempo de consulta: 0.26s Limitar resultados
  1. 24121
    “…Time to publication was significantly shorter when trials involved both European and non-European countries (26 vs 69 months [median]; hazard ratio = 0.38, 95% CI 0.22–0.66, p< 0.001), and were registered in both EU CTR and clinicaltrials.gov (27 vs 88 months; hazard ratio = 0.24, 95% CI 0.11–0.54; p< 0.001) based on survival analyses. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Publication of clinical trials on medicinal products: follow-up on trials authorized in Hungary
  2. 24122
    “…A total of 22 studies originated from EU, 90 from Far East, 16 from Middle East and 30 from America. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis
  3. 24123
    “…En effet, seulement 7,8 % (25/320) patients ont eu des tests cutanés préalables à la vaccination. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Suspicion d’allergie aux vaccins anti-COVID-19 : étude rétrospective sur la prise en charge de 320 patients
  4. 24124
    “…We analyzed neuropsychological outcome for long-term ATRT-survivors registered in EU-RHAB and infant low-grade glioma (LGG) survivors from the SIOP-LGG 2004-study and LGG-registry. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ATRT-02. Neuropsychological function in infant atypical teratoid/rhabdoid tumor versus low-grade glioma survivors reflects tumor malignancy and multimodal treatment
  5. 24125
    “…Atypical teratoid/rhabdoid tumors (n=36) were treated by EU-RHAB-Protocol with 3y-PFS/OS of 42.2 ± 9.4 % and 62.8 ± 9.5 %. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LINC-03. A single center retrospective analysis of current therapy and outcome of central nervous system tumors in children of Beijing
  6. 24126
    “…Thus, selecting for lower emitting animals indirectly through RFI could be a short-term strategy in order to achieve the intended reduction set by the EU Commission (-55% for 2030). The objectives were to 1) estimate genetic parameters for six methane traits, including genetic correlations between methane traits, production, and feed efficiency traits, 2) evaluate the expected correlated response of methane traits when selecting for feed efficiency with or without including methane, 3) quantify the impact of reducing methane emissions in dairy cattle using the Danish Holstein population as an example. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Selecting for Feed Efficient Cows Will Help to Reduce Methane Gas Emissions
  7. 24127
    “…METHODS: We employ a validated survey tool, the 47-item European Health Literacy Questionnaire (HLS-EU-Q). In addition to the 47 questions in the domains of health care, disease prevention, and health promotion, the participants’ demographic and socioeconomic characteristics are assessed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Level of health literacy in Latvia and Lithuania: a population-based study
  8. 24128
    “…Ninety-five control EEGs were acquired from two independent studies [Chowdhury et al. (2014) and EU-AIMS Longitudinal European Autism Project]. We extracted frequency and functional network-based features from 10 to 20 s epochs of resting-state EEG, including relative power spectral density, peak alpha frequency, network topology measures and brain network ictogenicity: a computational measure of the propensity of networks to generate seizure dynamics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Heterogeneity of resting-state EEG features in juvenile myoclonic epilepsy and controls
  9. 24129
    “…Clinical Trial Registration: https://www.clinicaltrialsregister.eu/ctr-search/search/, identifier Nr. 2020-003438-19…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers
  10. 24130
    “…Trial registration: ClinicalTrials.gov (https://clinicaltrials.gov/): NCT05402891 (June 1, 2022) and the EU Clinical Trials Register: EuraCT 2022-000240-30 (January 1, 2022). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The CHAMP-study: the CHemopreventive effect of lithium in familial AdenoMatous Polyposis; study protocol of a phase II trial
  11. 24131
    por Palazón-Carrión, Natalia, Martín García-Sancho, Alejandro, Nogales-Fernández, Esteban, Jiménez-Cortegana, Carlos, Carnicero-González, Fernando, Ríos-Herranz, Eduardo, de la Cruz-Vicente, Fátima, Rodríguez-García, Guillermo, Fernández-Álvarez, Rubén, Martínez-Banaclocha, Natividad, Gumà-Padrò, Josep, Gómez-Codina, José, Salar-Silvestre, Antonio, Rodríguez-Abreu, Delvys, Gálvez-Carvajal, Laura, Labrador, Jorge, Guirado-Risueño, María, García-Domínguez, Daniel J., Hontecillas-Prieto, Lourdes, Espejo-García, Pablo, Fernández-Román, Isabel, Provencio-Pulla, Mariano, Sánchez-Beato, Margarita, Navarro, Marta, Marylene, Lejeune, Álvaro-Naranjo, Tomás, Casanova-Espinosa, Maria, Sánchez-Margalet, Victor, Rueda-Domínguez, Antonio, de la Cruz-Merino, Luis
    Publicado 2022
    “…Secondary endpoints included progression-free survival (PFS), overall survival (OS), safety, and monitorization of key circulating immune biomarkers (EU Clinical Trials Register number: EudraCT 2014-001620-29). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis
  12. 24132
    por Spivack, O., Gaillard, L.
    Publicado 2022
    “…The number of live births per country in 2017 was retrieved from EUROSTAT, the EU’s statistical office. The number of new patients reported per country and the number of live births were used to generate country-specific prevalence figures per 10,000 live births. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ERN CRANIO patient coverage of craniosynostosis in Europe
  13. 24133
    “…RÉSULTATS: La réponse vaccinale a été observée chez 70 sur 110 patients après avoir appliqué les critères de l’exclusion. 84,3 % ont un taux d’IgG anti-SPIKE satisfaisant. 15,7 % ont un taux moins ou non satisfaisant. Les patients ayant eu un antécédent de SARS COV2 ont mieux répondu au vaccin. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Le taux d’anticorps anti-COVID19 à distance de la troisième dose de vaccin en hémodialyse
  14. 24134
    “…CLINICAL TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT04472429; https://clinicaltrialsregister.eu/ctr-search/search?query=2020-000826-24…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    POD1UM-303/InterAACT 2: A phase III, global, randomized, double-blind study of retifanlimab or placebo plus carboplatin–paclitaxel in patients with locally advanced or metastatic squamous cell anal carcinoma
  15. 24135
    “…The mean light REY (LREY)-to-heavy REY (HREY) ratio is 26.33. The mean values of δEu, δCe, Y, and Gd are 0.60, 0.99, 1.07, and 1.02, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Major and Rare Earth Element Characteristics of Late Paleozoic Coal in the Southeastern Qinshui Basin: Implications for Depositional Environments and Provenance
  16. 24136
    “…The plots of major element ratios including iron oxide/potasium oxide (Fe(2)O/K(2)O) against silicium oxide/aluminium oxide (SiO(2)/Al(2)O(3)) combined with that of sodium oxide/potassium oxide (Na(2)O/K(2)O) compared to silicium oxide/aluminium oxide (SiO(2)/Al(2)O(3)) are characteristic of greywacke and shale with few arkoses. The pronounced Eu negative anomaly of chondrite normalized REEs along with the plot of La/Th vs Hf and Co/Th vs La/Sc suggest that sediments are in general from felsic and intermediate source rock provenance, only subordinated contribution of mafic source. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Provenance, paleoweathering, depositional setting and paleoclimatic constraints of cretaceous and neogene deposits of The Mamfe Basin, southwest Cameroon
  17. 24137
    “…Future clinical trials could stratify patients treated at optimal times compared to those scheduled normally. FUNDING: EU-FP7.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
  18. 24138
    “…INTRODUCTION: Concerns over serious respiratory depression in children led to two European Union (EU) referral procedures (in 2013 and 2015) to review the benefit–risk balance of codeine in this population when used for pain relief, cough or cold. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe
  19. 24139
    “…TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT04462276 (Date of initial registration: 8th July 2020), https://clinicaltrials.gov/ct2/show/NCT04462276 Eudra-CT Number: 2019-003916-29 (Date of initial registration: 30th March 2020), https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-003916-29/DE…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial
  20. 24140
    “…METHODS: Here a sandwich TRFIA was optimized and established: Anti-S100A8/LRG1 caputre antibodies immobilized on 96-well plates captured S100A8/LRG1, and then banded together with the anti-S100A8/LRG1 detection antibodies labeled with Europium(III) (Eu(3+))/samarium(III) (Sm(3+)) chelates. Finally time resolved fluorometry measured the fluorescence intensity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A new method for screening acute/chronic lymphocytic leukemia: dual-label time-resolved fluorescence immunoassay
Herramientas de búsqueda: RSS